Preprint
Pandemic-response adenoviral vector and RNA vaccine manufacturing
Abstract
Abstract Rapid global COVID-19 pandemic response by mass vaccination is currently limited by the rate of vaccine manufacturing. This study presents a techno-economic feasibility assessment and comparison of three vaccine production platform technologies deployed during the COVID-19 pandemic: (1) adenovirus-vectored (AVV) vaccines, (2) messenger RNA (mRNA) vaccines, and (3) the newer self-amplifying RNA (saRNA) vaccines. Besides assessing the …
Authors
Kis Z; Tak K; Ibrahim D; Papathanasiou MM; Chachuat B; Shah N; Kontoravdi C
DOI
10.1101/2021.08.20.21262370
Preprint server
medRxiv